Search
Boston Scientific Corp
BSXAdd to Watchlist
47.800USD
+0.850+1.81%
Close 09-04 16:00（ET）
69.16BMarket Cap
19.89P/E TTM
Revenue Breakdown
Currency: USDUpdated: Fri, Aug 28
Currency: USDUpdated: Fri, Aug 28
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Interventional Cardiology Therapies
1.33B
24.49%
Electrophysiology
916.00M
16.83%
Endoscopy
793.00M
14.57%
Urology
684.00M
12.57%
Cardiac Rhythm Management
585.00M
10.75%
Other
1.13B
20.78%
By RegionUSD
Name
Revenue
Proportion
United States
3.43B
62.95%
EMEA (Europe, Middle East and Africa)
932.00M
17.13%
Asia Pacific
878.00M
16.13%
Latin America and Canada
206.00M
3.79%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Interventional Cardiology Therapies
1.33B
24.49%
Electrophysiology
916.00M
16.83%
Endoscopy
793.00M
14.57%
Urology
684.00M
12.57%
Cardiac Rhythm Management
585.00M
10.75%
Other
1.13B
20.78%